Administration of recombinant BMP9 reversed established PAH in Bmpr2 R899X knock-in mice, as well as in rat PAH models induced by monocrotaline or Sugen-Hypoxia. This evidence concerns the gene GDF2 and pulmonary arterial hypertension.